Investigator Did Not Document Adverse Effects, FDA Says

Devices & Diagnostics Letter
A A
The investigator in a device clinical trial failed to document adverse device effects, did not obtain informed consent from all participants and deviated from the investigational plan without approval, according to an FDA warning letter.

To View This Article:

Login

Subscribe To Devices & Diagnostics Letter